Previous 10 | Next 10 |
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced today a collaboration with Schrödinger, Inc., a company focused on transforming the way therapeutics are discovere...
-- Bill Banyai, Ph.D., to Lead DNA Data Storage and Technology Development -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the promotion of Patrick Wei...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 38th Annual J.P. Morgan H...
Risk reward analysis is a fundamental component of securities analysis. As we look to the first quarter of 2020, we view Twist Bioscience as having one of the worst risk rewards in the public market. Twist Bioscience ( TWST ) is a high flying “synthetic DNA” company trading...
The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2019 Q4 earnings Read more ...
Twist Bioscience Corporation (TWST) Q4 2019 Earnings Conference Call December 11, 2019, 04:30 PM ET Company Participants Jim Thorburn - CFO Emily Leproust - CEO and Co-Founder Conference Call Participants Doug Schenkel - Cowen Luke Sergott - Evercore Catherine Schulte - B...
Image source: The Motley Fool. Twist Bioscience Corp (NASDAQ: TWST) Q4 2019 Earnings Call Dec 11, 2019 , 4:30 p.m. ET Operator Continue reading
Gainers: AMRS +11.7% . GGB +4.9% . EVBG +4.3% . FREQ +2.8% . ACC +1.9% . More news on: Amyris, Inc., Gerdau S.A., Everbridge, Inc., Stocks on the move, , News on ETFs Read more ...
Twist Bioscience (NASDAQ: TWST ) fiscal Q4 results : More news on: Twist Bioscience Corporation, Healthcare stocks news, Earnings news and commentary, Read more ...
-- Fiscal 2019 Revenues Increase 114% over Fiscal 2018 to $54.4M-- -- Continued Strength in Synthetic Biology and NGS Businesses – -- Expect FY 2020 Revenues of $80M to $84M – Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...